2025
SJR Q1
JCR Q2 · 4,9
OA
26 matched articles
SCIE
Journal detail
Translational Oncology
- Publisher
- Neoplasia Press, Inc.
- Country
- United States · Northern America
- Type
- journal
- ISSN
-
1936523319447124
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 1,383
- Quartile Q1
- H-Index 84
- Cites/doc 5,03
- Docs (3y) 876
- Cites (3y) 4.301
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 4,9
- 5Y JIF 5,2
- JCI 0,98
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Cancer Research Q2
- Oncology Q1
WoS categories
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q2 | 1,383 | 4,9 | 5,2 | 0,98 | Q2 | 84 |
| 2024 | Q1 | Q2 | 1,408 | 4,1 | 4,6 | 1,05 | Q1 | 78 |
| 2023 | Q1 | Q1 | 1,263 | 4,5 | 4,2 | 1,06 | Q1 | 78 |
| 2022 | Q1 | Q2 | 1,15 | 5 | 4,6 | 1,01 | Q1 | 78 |
| 2021 | Q2 | Q2 | 1,06 | 4,8 | 4,7 | 0,87 | Q2 | 78 |
| 2020 | Q2 | Q2 | 1,343 | 4,2 | 4,2 | 0,88 | Q2 | 78 |
| 2019 | Q2 | Q2 | 1,267 | 3,6 | 3,5 | 0,88 | Q2 | 78 |
| 2018 | — | Q2 | — | 3,1 | 3,3 | 0,82 | Q2 | — |
| 2017 | Q2 | Q3 | 1,263 | 3,1 | 3,2 | 0,75 | Q2 | 78 |
| 2016 | Q1 | Q2 | 1,391 | 3 | 3,2 | — | — | 78 |
| 2015 | Q1 | Q2 | 1,431 | 3,1 | 3,1 | — | — | 78 |
| 2014 | Q1 | Q2 | 1,358 | 2,9 | 3,2 | — | — | 78 |
| 2013 | Q1 | Q3 | 1,296 | 2,6 | 3 | — | — | 78 |
| 2012 | Q1 | Q2 | 1,445 | 2,9 | — | — | — | 78 |
| 2011 | Q1 | Q2 | 1,624 | 3,4 | — | — | — | 78 |
| 2010 | Q2 | Q3 | 0,966 | 2,4 | — | — | — | 78 |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | ONCOLOGY | SCIE | Q2 | Q2 | 89/333 |
| 2024 | ONCOLOGY | SCIE | Q2 | Q1 | 91/328 |
| 2023 | ONCOLOGY | SCIE | Q1 | Q1 | 78/322 |
| 2022 | ONCOLOGY | SCIE | Q2 | Q1 | 77/241 |
| 2021 | ONCOLOGY | SCIE | Q2 | Q2 | 101/245 |
| 2020 | ONCOLOGY | SCIE | Q2 | Q2 | 118/242 |
| 2019 | ONCOLOGY | SCIE | Q2 | Q2 | 106/244 |
| 2018 | ONCOLOGY | SCIE | Q2 | Q2 | 110/230 |
| 2017 | ONCOLOGY | SCIE | Q3 | Q2 | 119/223 |
| 2016 | ONCOLOGY | SCIE | Q2 | — | 107/217 |
| 2015 | ONCOLOGY | SCIE | Q2 | — | 98/213 |
| 2014 | ONCOLOGY | SCIE | Q2 | — | 105/211 |
| 2013 | ONCOLOGY | SCIE | Q3 | — | 114/203 |
| 2012 | ONCOLOGY | SCIE | Q2 | — | 83/197 |
| 2011 | ONCOLOGY | SCIE | Q2 | — | 63/196 |
| 2010 | ONCOLOGY | SCIE | Q3 | — | 97/185 |